Ketamine-based nasal spray to treat depression approved in US

A new anti-depressant spray that’s chemically similar to the highly addictive drug, ketamine, has been approved in the US. Esketamine, as it’s known, comes with a strong government drug-agency warning about the risks associated with misuse & abuse. Early trials show positive results among patients with severe depression. READ MORE:


Check out

Subscribe to RT!

Like us on Facebook
Follow us on VK
Follow us on Twitter
Follow us on Instagram
Follow us on Google+

#RT (Russia Today) is a global #news network broadcasting from Moscow and Washington studios. RT is the first news channel to break the 1 billion YouTube views benchmark.